Plus Therapeutics (PSTV) announced it reported stockholders’ equity of $3M and therefore satisfied Nasdaq Listing Rule 5550(b)(1), as of June 30, 2025. The Equity Rule requires listed companies to maintain a minimum of $2.5 million in stockholders’ equity.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSTV:
- Buy Rating for Plus Therapeutics: Strategic Market Launch and Promising Financial Outlook
- Plus Therapeutics Reports Strong Q2 2025 Results
- Plus Therapeutics Awaits Nasdaq Compliance Confirmation
- Plus Therapeutics presents data from analysis of CNSide CSF Assay
- Plus Therapeutics Granted Continued Nasdaq Listing